Trial · NCT07914400
Timing of Oral Hygiene Improvement Relative to Subgingival Instrumentation
NCT07914400, Not applicable, Completed, University of Ljubljana
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Timing of Oral Hygiene Improvement Relative to Subgingival Instrumentation. Trials, record NCT07914400. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07914400
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Timing of Oral Hygiene Improvement Relative to Subgingival Instrumentation
- NCT number
- NCT07914400
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 10 participants, actual
- Lead sponsor
- University of Ljubljana
- Conditions
Periodontal Diseases Inflammation, Periodontal Disease, Periodontal Attachment Loss, Periodontal Pocket, Oral Hygiene, Oral Hygiene Education, Periodontal Therapy, Systemic Inflammation, High Sensitive C-reactive Protein (hsCRP)
- Interventions
- Nonsurgical periodontal treatment
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Probing pocket depth (PPD) | At baseline | Probing pocket depth measured using manual probe at 6 sites around each tooth. Unit: millimeters |
| Primary | Probing pocket depth (PPD) | 90 days after first intervention | Probing pocket depth measured using manual probe at 6 sites around each tooth. Unit: millimeters |
| Primary | Probing pocket depth (PPD) | 180 days after first intervention (90 days after second intervention) | Probing pocket depth measured using manual probe at 6 sites around each tooth. Unit: millimeters |
| Primary | Bleeding on probing (BOP) | At baseline | Yes/No after probing pocket depth measurement 6 sites around each tooth. Unit: % (bleeding sites/all sites) |
| Primary | Bleeding on probing (BOP) | 90 days after first intervention | Yes/No after probing pocket depth measurement 6 sites around each tooth. Unit: % (bleeding sites/all sites) |
| Primary | Bleeding on probing (BOP) | 180 days after first intervention (90 days after second intervention) | Yes/No after probing pocket depth measurement 6 sites around each tooth. Unit: % (bleeding sites/all sites) |
| Primary | Clinical attachment level (CAL) | At baseline | This is the measurement of the position of the soft tissue attachment in relation to the cemento-enamel junction (CEJ). Two measurements are used to calculate the CAL: the probing depth and the distance from the gingival margin to the CEJ. Unit: millimeters |
| Primary | Clinical attachment level (CAL) | 90 days after first intervention | This is the measurement of the position of the soft tissue attachment in relation to the cemento-enamel junction (CEJ). Two measurements are used to calculate the CAL: the probing depth and the distance from the gingival margin to the CEJ. Unit: millimeters |
| Primary | Clinical attachment level (CAL) | 180 days after first intervention (90 days after second intervention) | This is the measurement of the position of the soft tissue attachment in relation to the cemento-enamel junction (CEJ). Two measurements are used to calculate the CAL: the probing depth and the distance from the gingival margin to the CEJ. Unit: millimeters |
| Primary | Plaque index (PI) | At baseline | Yes/No at six sites around each tooth. Unit: % (sites with plaque/all sites) |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers6
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07914400
GET https://conductscience.org/api/trials/v1/NCT07914400/registered